Skip to main content

Home/ Cancer/ Group items tagged anti-copper inhibitor

Rss Feed Group items tagged

Matti Narkia

Tetrathiomolybdate copper reduction anti-angiogenesis cancer treatment - anticopper, TM. - 0 views

  •  
    WARNING: This page was NOT created or approved by any doctor or medical researcher. The purpose of this page is to provide hard-to-find information on copper reduction cancer treatment, a new unapproved and experimental course of cancer treatment whose ef
Matti Narkia

Tetrathiomolybdate Copper Reduction Therapy as an Antiangiogenic Treatment for Lymphoma... - 0 views

  •  
    The article is written by lay individuals for information purposes only and is not to be used to diagnose or treat any disease. The document outlines therapeutic strategies which have not been clinically proven and may not be effective for lymphoma and ot
Matti Narkia

Tetrathiomolybdate: Cancer Protocol. The Treatment and Management of Cancer Today. A re... - 0 views

  •  
    If angiogenesis controls cancer growth, what controls angiogenesis? Researchers at the University of Michigan and the University of South Florida believe that the copper status is critical to the function growth factors.
Matti Narkia

Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesi... - 0 views

  •  
    Q. Pan, C. G. Kleer, K. L. van Golen, J. Irani, K. M. Bottema, C. Bias, M. De Carvalho, E. A. Mesri, D. M. Robins, R. D. Dick, G. J. Brewer, and S. D. Merajver
    Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis
    Canc
Matti Narkia

Cancer Therapy With Tetrathiomolybdate: Antiangiogenesis by Lowering Body Copper-A Revi... - 0 views

  •  
    Brewer GJ, Merajver SD.
    Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
    Integr Cancer Ther. 2002 Dec;1(4):327-37. Review.
    PMID: 14664727 [PubMed - indexed for MEDLINE]
Matti Narkia

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer -- Redman ... - 0 views

  •  
    B. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. Merajver
    Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer
    Clin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
Matti Narkia

Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Coppe... - 0 views

  •  
    C. Cox, S. D. Merajver, S. Yoo, R. D. Dick, G. J. Brewer, J. S.-J. Lee, and T. N. Teknos
    Inhibition of the Growth of Squamous Cell Carcinoma by
    Tetrathiomolybdate-Induced Copper Suppression in a Murine Model
    Arch Otolaryngol Head Neck Surg, July 1, 200
Matti Narkia

Antiangiogenic Tetrathiomolybdate Enhances the Efficacy of Doxorubicin against Breast C... - 0 views

  •  
    Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD.
    Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.
    Mol Cancer Ther. 2003 Jul;2(7):617-22.
    PMID: 12883034 [PubMed - indexed for MEDLINE]
1 - 8 of 8
Showing 20 items per page